International Journal of Molecular and Immuno Oncology

Most Viewed Articles

Total Downloads
1,429,367
Fulltext
962,138
PDF
467,229

Articles	Fulltext downloads	PDF downloads	Total downloads
Short Communication Driver mutations in oncogenesis Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_26_2020	27,863	3,007	30,870
Review Article Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2023	22,983	1,982	24,965
Original Article Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_15_2023	21,874	1,860	23,734
Editorial Challenging conventional wisdom in molecular oncology: New perspectives Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2023	21,853	1,838	23,691
Review Article Molecular oncology and the role of artificial intelligence in advancing cancer treatment Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_17_2023	21,617	1,328	22,945
Short Communication Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_30_2020	18,587	2,547	21,134
Case Report *Long-term efficacy of osimertinib in de novo* exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India** Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_16_2023	18,311	1,453	19,764
News Editorial board tribute to Dr. Amit Verma Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December	14,910	1,925	16,835
Review Article Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_8_2022	12,501	4,230	16,731
Case Report Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_5_2022	11,507	4,868	16,375
Case Report Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2023	13,979	1,755	15,734
Case Report Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_16_2021	13,607	1,709	15,316
Cardio Oncology with ACOS Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_1_2022	11,408	3,705	15,113
New Drug Update Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2021	13,405	1,679	15,084
Review Article Potential therapeutic molecular targets for better outcomes for patients with lung cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_27_2022	14,399	669	15,068
Review Article Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_29_2022	13,514	1,538	15,052
Review Article Combination of PARPi and anti-PD-L1 therapies in ovarian cancer Full text \| PDF Year: 2023, Volume: 8, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2022	14,167	868	15,035
Original Article Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change? Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_2_2022	10,888	3,741	14,629
Review Article Immune dynamics of SARS-CoV-2 virus evolution Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_26_2021	10,125	3,947	14,072
Case Series Dual driver in non-small cell lung carcinoma – therapeutic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2021	11,788	2,045	13,833
Review Article Is continuous infusion of high-dose ifosfamide, a safe option? Drug review Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_21_2019	10,874	2,850	13,724
Review Article Advances in immunotherapy for metastatic esophageal cancer Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_14_2022	9,949	3,740	13,689
Case Report L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report Full text \| PDF Year: 2023, Volume: 8, Issue: 3, September-December DOI: 10.25259/IJMIO_11_2023	12,297	1,041	13,338
Review Article Immuno-oncological era of breast cancer: A progressive path to better treatment Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_3_2022	8,583	4,682	13,265
Review Article The evolving role of precision medicine in the management of advanced sarcomas – A mini review Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_6_2021	11,251	1,978	13,229
Editorial Nanobytes Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2019	6,367	6,644	13,011
Case Report Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_11_2022	10,659	2,341	13,000
Review Article Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_12_2021	10,704	2,177	12,881
Review Article Immuno-oncology of differentiated thyroid cancer Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_36_2020	10,056	2,683	12,739
Conference Review 6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_20_2021	10,918	1,563	12,481
Brief Commentary ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_10_2021	10,286	2,169	12,455
Review Article A compendium of population wide DNA methylation profile for oral cancer in India Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_2_2021	9,366	3,022	12,388
Erratum Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020) Full text \| PDF Year: 2021, Volume: 6, Issue: 2, October DOI: 10.25259/IJMIO_05_2020_ER	11,212	1,148	12,360
Case Report Complete metabolic response with letrozole and palbociclib in advanced breast cancer Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_2_2019	7,859	4,498	12,357
Case Report Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma Full text \| PDF Year: 2022, Volume: 7, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2021	10,527	1,718	12,245
Brief Commentary Breast cancer prognostic tools: A promising Indian option Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_15_2020	8,404	3,727	12,131
Editorial Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_2_2024	10,248	1,469	11,717
Brief Commentary Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management Full text \| PDF Year: 2021, Volume: 6, Issue: 3, September-December DOI: 10.25259/IJMIO_7_2021	9,479	2,151	11,630
Letter to Editor Letter to editor Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_10_2022	7,941	3,688	11,629
Case Report Metastatic endometrial carcinoma responsive to pembrolizumab Full text \| PDF Year: 2021, Volume: 6, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2020	6,711	4,886	11,597
Review Article High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_1_2024	10,522	1,051	11,573
Review Article Understanding immunotherapy and CAR-T-cells: A narrative review Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_22_2023	10,434	1,135	11,569
Review Article Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications Full text \| PDF Year: 2022, Volume: 7, Issue: 2, May – August DOI: 10.25259/IJMIO_12_2022	7,397	4,158	11,555
Review Article Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_18_2019	6,374	5,070	11,444
Review Article Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article Full text \| PDF Year: 2024, Volume: 9, Issue: 1, January-April DOI: 10.25259/IJMIO_3_2024	10,301	1,025	11,326
Review Article The Cancer Genomic Atlas – “TO CONQUER CANCER” Full text \| PDF Year: 2021, Volume: 6, Issue: 2, May-August DOI: 10.25259/IJMIO_28_2020	8,840	2,466	11,306
Review Article *Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ* hybridization and Immunohistochemistry: A meta-analysis with systematic review** Full text \| PDF Year: 2020, Volume: 5, Issue: 1, January-April DOI: 10.25259/IJMIO_17_2019	5,818	5,387	11,205
Review Article Molecular genetics changes in gallbladder carcinoma Full text \| PDF Year: 2020, Volume: 5, Issue: 2, May-August DOI: 10.25259/IJMIO_19_2019	7,722	3,375	11,097
Original Article Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India Full text \| PDF Year: 2019, Volume: 4, Issue: 3, September-December DOI: 10.25259/IJMIO_1_2019	5,313	5,748	11,061
Case Report A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung Full text \| PDF Year: 2022, Volume: 7, Issue: 3, September-December DOI: 10.25259/IJMIO_13_2022	8,697	2,063	10,760

Most Viewed Articles

Driver mutations in oncogenesis

Mini review: Molecular pathology of personalized medicine in cancer susceptibility syndromes

Outcomes with atezolizumab and bevacizumab in hepatocellular carcinoma – Real-world data from India

Challenging conventional wisdom in molecular oncology: New perspectives

Molecular oncology and the role of artificial intelligence in advancing cancer treatment

Outcome of ivermectin and doxycycline in cancer patients with COVID-19: A positive experience in Bangladesh

Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India

Editorial board tribute to Dr. Amit Verma

Can CDK 4/6 inhibitors be used in patients with visceral crises? Deviating from conventional teaching

Clinical experience of total body irradiation performed on Halcyon™ for a patient diagnosed with acute myeloid leukemia

Squamous cell carcinoma of lung presenting as “Sunray sign” in chest radiograph

Hyperthermic intraperitoneal chemotherapy in primary peritoneal cancer: Our experience in a young male

Ibrutinib and atrial fibrillation as cardiotoxicity – A new safety warning that impacts overall survival

Amlodipine-induced inhibition of NFAT-2 nuclear translocation and its utility as an additive to immune checkpoint inhibitor

Potential therapeutic molecular targets for better outcomes for patients with lung cancer

Signaling pathways in pancreatic ductile adenocarcinoma and potential therapeutic targets

Combination of PARPi and anti-PD-L1 therapies in ovarian cancer

Incorporation of immunohistochemistry in the assessment of survival and prognosis of endometrial cancers: Are we ready for the change?

Immune dynamics of SARS-CoV-2 virus evolution

Dual driver in non-small cell lung carcinoma – therapeutic dilemma

Is continuous infusion of high-dose ifosfamide, a safe option? Drug review

Advances in immunotherapy for metastatic esophageal cancer

L1CAM expressing, ZFTA:: NCOA1 fusion-positive supratentorial ependymoma: A case report

Immuno-oncological era of breast cancer: A progressive path to better treatment

The evolving role of precision medicine in the management of advanced sarcomas – A mini review

Nanobytes

Redefining the treatment of metastatic uveal melanoma with immunotherapy – A case report

Post-chemotherapy maintenance treatment by nicotinamide riboside, a poly ADP ribose polymerase 1 inhibitor, in BRCA mutated advanced ovarian cancer – A perspective

Immuno-oncology of differentiated thyroid cancer

6th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

ERBB and FGFR2 pathway inhibition in biliary tract cancers – Dawn of a new beginning

A compendium of population wide DNA methylation profile for oral cancer in India

Erratum for manuscript “Muir Torre Syndrome – An Indian Case report” (IJMIO_5_2020)

Complete metabolic response with letrozole and palbociclib in advanced breast cancer

Unusual presentation of an Epstein barr virus-negative extranodal natural killer/T cell lymphoma: A diagnostic dilemma

Breast cancer prognostic tools: A promising Indian option

Crucial crossroads: Making the right choice for first-line therapy in advanced urothelial cancer

Bioactive lipid: A novel diagnostic approach for retinoblastoma in clinical management

Letter to editor

Metastatic endometrial carcinoma responsive to pembrolizumab

High-dose nicotinamide, a histone deacetylase inhibitor (Sirtuin-1), can prevent emergence of treatment resistance in chronic myeloid leukemia – A perspective

Understanding immunotherapy and CAR-T-cells: A narrative review

Resistance to poly ADP-ribose polymerase inhibitors and its clinical implications

Cell biological basis of tumor relapse and recurrence – A help from yeast quiescent biology and neuronal quiescent cell biology

Use of five-day chronomodulated prescription of palbociclib as myelopreservation drug along with Topotecan in recurrent extensive stage small cell lung carcinoma – A perspective article

The Cancer Genomic Atlas – “TO CONQUER CANCER”

Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review

Molecular genetics changes in gallbladder carcinoma

Real World Outcomes of Check Point Inhibitors Immunotherapy in Renal and Urothelial Cancers in a Teratiary Care Cancer Center in India

A rare case of Exon 19 deletion transforming to Exon 20 insertion in a case of adenocarcinoma of lung

**Long-term efficacy of osimertinib in de novo exon 19 deletion with T790M in an epidermal growth factor receptor mutated lung cancer patient in India**

6^th Molecular Oncology Society Conference: Improving patient survival by molecularly targeted therapies

**Impact of 2013 ASCO/CAP guidelines on various HER2 reporting categories in breast cancer by fluorescent in-situ hybridization and Immunohistochemistry: A meta-analysis with systematic review**